AiM  Vol.8 No.7 , July 2018
Analysis of Hyaluronidase Expression by qPCR in Egyptian Clinical Isolates of Staphylococcus aureus and Its Correlation with Phenotypic Plate Assay
Abstract: Hyaluronidase enzyme (HysA) is an extracellular enzyme that is considered to be an important virulence factor for Staphylococcus aureus. We screened the production of HysA enzyme in the spent media of Egyptian clinical isolates (32 isolates) via phenotypic plate assay. We found that 75% of the isolates (24 isolates) were able to produce HysA enzyme. We designed primers for qPCR analysis of hysA mRNA expression that was derived from the alignment of hysA gene sequences of 41 strains of S. aureus. The designed primers could be used for the amplification of hysA in 79.2% of the isolates (19 isolates) that were positive for HysA production as demonstrated by phenotypic plate assay. A significant positive correlation, as indicated by Pearson correlation analysis (r = 0.84 at P < 0.001), was found between phenotypic plate assay and qPCR of mRNA expression of hysA in the investigated isolates of S. aureus. In conclusion, we analyzed for the first time hysA mRNA expression via qPCR in S. aureus. Additionally, our work showed a good agreement between the phenotypic assay of HysA production via plate assay and hysA expression in S. aureus. The qPCR analysis of this study could be used as a more reliable quantitative method for hysA expression analysis particularly in infected animal models of S. aureus.
Cite this paper: Abdelkader, S. , El-Mowafy, M. , Abdelmegeed, E. and Hassan, R. (2018) Analysis of Hyaluronidase Expression by qPCR in Egyptian Clinical Isolates of Staphylococcus aureus and Its Correlation with Phenotypic Plate Assay. Advances in Microbiology, 8, 614-624. doi: 10.4236/aim.2018.87041.

[1]   Styers, D., Sheehan, D.J., Hogan, P. and Sahm, D.F. (2006) Laboratory-Based Surveillance of Current Antimicrobial Resistance Patterns and Trends among Staphylococcus aureus: 2005 Status in the United States. Annals of Clinical Microbiology and Antimicrobials, 5, 2.

[2]   Hoerr, V., Franz, M., Pletz, M.W., Diab, M., Niemann, S., Faber, C., Doenst, T., Schulze, P.C., Deinhardt-Emmer, S. and Loffler, B. (2018) S. aureus Endocarditis: Clinical Aspects and Experimental Approaches. International Journal of Medical Microbiology.

[3]   Heriot, G.S., Tong, S.Y., Cheng, A.C. and Liew, D. (2018) What Risk of Endocarditis Is Low Enough to Justify the Omission of Transoesophageal Echocardiography in Staphylococcus aureus Bacteraemia? A Narrative Review. Clinical Microbiology and Infection.

[4]   Lacey, K.A., Geoghegan, J.A. and McLoughlin, R.M. (2016) The Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine Antigens. Pathogens, 5, 22.

[5]   Powers, M.E. and Bubeck Wardenburg, J. (2014) Igniting the Fire: Staphylococcus aureus Virulence Factors in the Pathogenesis of Sepsis. PLoS Pathogens, 10, e1003871.

[6]   Kong, C., Chee, C.F., Richter, K., Thomas, N., Abd Rahman, N. and Nathan, S. (2018) Suppression of Staphylococcus aureus Biofilm Formation and Virulence by a Benzimidazole Derivative, UM-C162. Scientific Reports, 8, 2758.

[7]   Stern, R. and Jedrzejas, M.J. (2006) Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action. Chemical Reviews, 106, 818-839.

[8]   Hart, M.E., Tsang, L.H., Deck, J., Daily, S.T., Jones, R.C., Liu, H., Hu, H., Hart, M.J. and Smeltzer, M.S. (2013) Hyaluronidase Expression and Biofilm Involvement in Staphylococcus aureus UAMS-1 and Its sarA, agr and sarA agr Regulatory Mutants. Microbiology, 159, 782-791.

[9]   Hynes, W.L. and Walton, S.L. (2000) Hyaluronidases of Gram-Positive Bacteria. FEMS Microbiology Letters, 183, 201-207.

[10]   Girish, K.S. and Kemparaju, K. (2007) The Magic Glue Hyaluronan and Its Eraser Hyaluronidase: A Biological Overview. Life Science, 80, 1921-1943.

[11]   Jiang, D., Liang, J. and Noble, P.W. (2011) Hyaluronan as an Immune Regulator in Human Diseases. Physiological Reviews, 91, 221-264.

[12]   Sonoda, M., Harwood, F.L., Amiel, M.E., Moriya, H., Temple, M., Chang, D.G., Lottman, L.M., Sah, R.L. and Amiel, D. (2000) The Effects of Hyaluronan on Tissue Healing after Meniscus Injury and Repair in a Rabbit Model. The American Journal of Sports Medicine, 28, 90-97.

[13]   Lowy, F.D. (1998) Staphylococcus aureus Infections. The New England Journal of Medicine, 339, 520-532.

[14]   Makris, G., Wright, J.D., Ingham, E. and Holland, K.T. (2004) The Hyaluronate Lyase of Staphylococcus aureus—A Virulence Factor? Microbiology, 150, 2005-2013.

[15]   Smith, R.F. and Willett, N.P. (1968) Rapid Plate Method for Screening Hyaluronidase and Chondroitin Sulfatase-Producing Microorganisms. Journal of Applied Microbiology, 16, 1434-1436.

[16]   Joslyn, D.A. and Galbraith, M. (1947) A Turbidimetric Method for the Assay of Antibiotics. Journal of Bacteriology, 54, 26.

[17]   Vercruysse, K.P., Lauwers, A.R. and Demeester, J.M. (1995) Absolute and Empirical Determination of the Enzymatic Activity and Kinetic Investigation of the Action of Hyaluronidase on Hyaluronan Using Viscosimetry. Biochemical Journal, 306, 153-160.

[18]   Muckenschnabel, I., Bernhardt, G., Spruss, T., Dietl, B. and Buschauer, A. (1998) Quantitation of Hyaluronidases by the Morgan-Elson Reaction: Comparison of the Enzyme Activities in the Plasma of Tumor Patients and Healthy Volunteers. Cancer Letters, 131, 13-20.

[19]   Steiner, B. and Cruce, D. (1992) A Zymographic Assay for Detection of Hyaluronidase Activity on Polyacrylamide Gels and Its Application to Enzymatic Activity Found in Bacteria. Analytical Biochemistry, 200, 405-410.

[20]   Duthie, E.S. and Lorenz, L.L. (1952) Staphylococcal Coagulase; Mode of Action and Antigenicity. Journal of General Microbiology, 6, 95-107.

[21]   Duquenne, M., Fleurot, I., Aigle, M., Darrigo, C., Borezée-Durant, E., Derzelle, S., Bouix, M., Deperrois-Lafarge, V. and Delacroix-Buchet, A. (2010) Tool for Quantification of Staphylococcal Enterotoxin Gene Expression in Cheese. Applied and Environmental Microbiology, 76, 1367-1374.

[22]   Pfaffl, M.W. (2001) A New Mathematical Model for Relative Quantification in Real-Time RT-PCR. Nucleic Acids Research, 29, e45.

[23]   Choudhuri, K.K. and Chakrabarty, A.N. (1969) Hyaluronate Lyase Activity of Staphylococci. Indian Journal of Experimental Biology, 7, 183-185.

[24]   Essers, L. and Radebold, K. (1980) Rapid and Reliable Identification of Staphylococcus aureus by a Latex Agglutination Test. Journal of Clinical Microbiology, 12, 641-643.

[25]   Hart, M.E., Hart, M.J. and Roop, A.J. (2009) Genotypic and Phenotypic Assessment of Hyaluronidase among Type Strains of a Select Group of Staphylococcal Species. International Journal of Microbiology, 2009, Article ID: 614371.

[26]   Boswihi, S.S., Udo, E.E. and Al-Sweih, N. (2016) Shifts in the Clonal Distribution of Methicillin-Resistant Staphylococcus aureus in Kuwait Hospitals: 1992-2010. PLoS ONE, 11, e0162744.

[27]   Khaledi, A., Schniederjans, M., Pohl, S., Rainer, R., Bodenhofer, U., Xia, B., Klawonn, F., Bruchmann, S., Preusse, M., Eckweiler, D., Dotsch, A. and Haussler, S. (2016) Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 60, 4722-4733.

[28]   Janjua, H.A., Segata, N., Bernabo, P., Tamburini, S., Ellen, A. and Jousson, O. (2012) Clinical Populations of Pseudomonas aeruginosa Isolated from Acute Infections Show a Wide Virulence Range Partially Correlated with Population Structure and Virulence Gene Expression. Microbiology, 158, 2089-2098.

[29]   Zelezniak, A., Sheridan, S. and Patil, K.R. (2014) Contribution of Network Connectivity in Determining the Relationship between Gene Expression and Metabolite Concentration Changes. PLOS Computational Biology, 10, e1003572.

[30]   Caldwell, R., Sapolsky, R., Weyler, W., Maile, R.R., Causey, S.C. and Ferrari, E. (2001) Correlation between Bacillus subtilis scoC Phenotype and Gene Expression Determined Using Microarrays for Transcriptome Analysis. Journal of Bacteriology, 183, 7329-7340.